For patients with advanced prostate cancer, enzalutamide capsules (also known as Enzabuzz 40 mg capsules) provide important advantages. This cancer capsule slows the development of cancer cells by blocking androgen receptors. For metastatic castration-resistant prostate cancer (mCRPC), enzalutamide - Enzabuzz 40 mg capsule is beneficial in extending survival and increasing quality of life. Oral administration is a recommended choice due to its simplicity and mild adverse effects, such as hypertension and weariness. All things considered, the 40 mg Enzalutamide-Enzabuzz tablet offers advanced prostate cancer patients real advantages and hope.